title: Reply from authors re: Bertrand Tombal. Zometa European Study (ZEUS): another failed crusade for the holy grail of prostate cancer bone metastases prevention? Eur Urol 2015;67:492-4: ZEUS: the quest for the holy grail of prostate cancer bone metastases prevention continues.
authors.affiliation: European Association of Urology Research Foundation, Arnhem, The Netherlands. Electronic address: w.witjes@curatrial.com.
authors.forename: Wim P J
authors.initials: WP
authors.lastname: Witjes
authors.affiliation: European Association of Urology Research Foundation, Arnhem, The Netherlands.
authors.forename: Anup
authors.initials: A
authors.lastname: Patel
authors.affiliation: University Clinic Carl Gustav Carus, Urology, Dresden, Germany.
authors.forename: Manfred
authors.initials: M
authors.lastname: Wirth
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000517:prevention & control*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles